Related news from
Thu, 18 Apr 2024 21:24:00 +0000	Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024 PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the release of the Company’s first quarter 2024 financial results to Monday, May 6, 2024. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. EDT. A live webcast will be available on the Investors section of the Company’s website at investor.integr
Thu, 18 Apr 2024 14:01:51 +0000	Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wed, 17 Apr 2024 14:01:18 +0000	Earnings Preview: Integra LifeSciences (IART) Q1 Earnings Expected to Decline Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tue, 09 Apr 2024 12:41:00 +0000	Here's Why Investors Should Retain Integra (IART) Stock Now Integra's (IART) strong focus on portfolio optimization and international expansion bolsters investors' confidence in the stock.
Mon, 01 Apr 2024 20:15:00 +0000	Integra LifeSciences Completes the Acquisition of Acclarent, Inc. PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of Acclarent, Inc., a pioneer in ear, nose and throat (ENT) surgical interventions. The addition of Acclarent's innovative product portfolio expands the breadth of Integra’s market-leading brands and provides immediate scale and accretive growth via a dedicated sales channel. The acq
Sun, 31 Mar 2024 14:58:56 +0000	Integra LifeSciences Holdings' (NASDAQ:IART) earnings have declined over three years, contributing to shareholders 48% loss For many investors, the main point of stock picking is to generate higher returns than the overall market. But if you...
Fri, 29 Mar 2024 15:30:33 +0000	Why Is Integra (IART) Down 4% Since Last Earnings Report? Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wed, 13 Mar 2024 12:17:14 +0000	11 Oversold Healthcare Stocks To Buy Right Now In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Oversold Healthcare Stocks To Buy Right Now. The Healthcare Sector: The New 2024 Idea? The healthcare sector has been popular […]
Tue, 12 Mar 2024 16:04:00 +0000	Integra LifeSciences (IART) Introduces MicroMatrix Flex Integra LifeSciences' (IART) MicroMatrix Flex has a flexible tip that delivers a flowable version of the Urinary Bladder Matrix (UBM) technology.
Mon, 11 Mar 2024 12:30:00 +0000	Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases Novel system features flexible tip to deliver flowable version of the Urinary Bladder Matrix (UBM) technology MicroMatrix®Flex MicroMatrix®Flex is a dual-syringe system enabling the convenient mixing and precise delivery of MicroMatrix® paste. PRINCETON, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced MicroMatrix® Flex is now available commercially in the U.S. MicroMatrix Flex is a dual-syringe system enabling the convenient mixin
Fri, 01 Mar 2024 10:59:24 +0000	Integra LifeSciences Holdings Full Year 2023 Earnings: EPS Misses Expectations Integra LifeSciences Holdings ( NASDAQ:IART ) Full Year 2023 Results Key Financial Results Revenue: US$1.54b (down 1.0...
Thu, 29 Feb 2024 16:46:33 +0000	Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2023 Earnings Call Transcript Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2023 Earnings Call Transcript February 28, 2024 Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $0.89 EPS, expectations were $0.9. Integra LifeSciences Holdings Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good […]
Thu, 29 Feb 2024 15:43:00 +0000	Integra's (IART) Q4 Earnings Miss Estimates, Margins Down Integra's (IART) Q4 revenues are impacted by the decline in the Tissue Technologies segment.
Thu, 29 Feb 2024 10:52:12 +0000	Integra Lifesciences CEO Jan De Witte to retire The company is working to restart a factory in Boston after problems at the plant led to a sweeping recall in 2023. De Witte will stay with Integra until it finds a successor.
Thu, 29 Feb 2024 03:46:18 +0000	Q4 2023 Integra Lifesciences Holdings Corp Earnings Call Q4 2023 Integra Lifesciences Holdings Corp Earnings Call
Wed, 28 Feb 2024 14:30:14 +0000	Compared to Estimates, Integra (IART) Q4 Earnings: A Look at Key Metrics The headline numbers for Integra (IART) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Wed, 28 Feb 2024 12:15:04 +0000	Integra LifeSciences (IART) Misses Q4 Earnings and Revenue Estimates Integra (IART) delivered earnings and revenue surprises of -1.11% and 0.44%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Wed, 28 Feb 2024 11:32:18 +0000	Integra Lifesciences Reports Subdued Earnings Amidst Market Stability and Product Resilience Full-Year Revenue Sees Slight Decline as Company Prepares for 2024 with Strategic Acquisitions and Product Relaunches
Wed, 28 Feb 2024 11:00:00 +0000	Integra LifeSciences Announces Leadership Transition Plan Jan De Witte to retire as CEO by the end of 2024Stuart Essig appointed executive chairman of the Board PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (“Integra” or “the Company”) (NASDAQ: IART), a leading global medical technology company, today announced that Jan De Witte has informed the Board of Directors (the “Board”) of his intention to retire from his position as president and chief executive officer of Integra following the appointment of a su
Wed, 28 Feb 2024 11:00:00 +0000	Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Reported revenues were $397.0 million, representing a decrease of 0.2% on a reported basis and a decrease of 1.2% on an organic basis compared to the fourth quarter 2022. Revenue increased 3.6% on an organic basis excluding Boston. GAAP earnings per diluted share were $0.25, c